Amman-Mubasher: The Jordanian Pharmaceutical Manufacturing reported a 7.89% rise in losses to JOD 6.1 million ($8.6 million) in the first half of 2015, compared to JOD 5.7 million ($8 million) in the same period of 2014, according to a bourse filing.

In the first quarter of this year, the company’s losses deepened by 47% to JOD 2.42 million ($3.41 million), compared to JOD 1.65 million ($2.33 million) in Q1-14.